Viewing nowCombinationTelmisartan/Amlodipine 40/5 mg
Telmisartan 40mg · Amlodipine Besylate 6.935mg
Tablet · Prescription medication · Combination
Hanwha Pharmaceutical Co., Ltd.

MFDS item code 201606793 · Approved 2016.11.29 · Insurance code 651602200
Treatment of essential hypertension not controlled with monotherapy
Used for patients with essential hypertension whose blood pressure is not adequately controlled with monotherapy of amlodipine or telmisartan. This medication effectively lowers blood pressure, helping to prevent cardiovascular complications. It can be considered as an additional treatment option when blood pressure control is difficult.
The recommended dose of this medicine is 1 tablet once daily, taken with water, regardless of meals. It is recommended that it be taken at the same time each day, if possible (e.g., in the morning). It is recommended that the dose be adjusted using the individual components (amlodipine or telmisartan) before administering this medicine. However, switching directly to this medicine may be considered if blood pressure is not controlled with the individual components, as follows: - 40/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or this medicine 40/5 mg. - 40/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg. - 80/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg or this medicine 40/10 mg. Patients taking telmisartan and amlodipine concomitantly may switch to this medicine (a combination product containing the same amount of each active ingredient) for convenience (limited to this medicine 40/5 mg and 80/10 mg). ○ Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. In patients with severe renal impairment, however, it is recommended to start treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 mg in patients with mild or moderate hepatic impairment. ◦ Older adults: The usual amlodipine dosage regimen is recommended for older adults, but caution should be exercised when increasing the dose (see section '3. Patients who should use this medicine with caution'). In older adults aged 75 years and above, amlodipine clearance is reduced; therefore, start treatment at a low dose and increase the dose gradually.
The safety and efficacy of this medicine have not been established in pediatric patients 18 years of age or younger; therefore, its use is not recommended.
This medication can pose serious risks to the fetus during pregnancy, especially in the second and third trimesters, therefore it should not be taken by pregnant women or women who may become pregnant. This drug should not be given to patients with certain conditions, such as liver impairment, severe hypotension, heart-related diseases, or those who have hypersensitivity to certain medications. Additionally, special caution is required for patients with primary aldosteronism, those with impaired kidney function, gastrointestinal disorders, and elderly patients. Side effects such as dizziness or peripheral edema may occur during treatment, and in severe cases, syncope or cardiac problems may arise, thus if any abnormalities occur, immediate consultation with healthcare professionals is advised. Cases of dangerously low blood pressure may occur, so patients with fluid or salt depletion should discuss with their physician before taking the medication, and appropriate treatment is necessary if symptoms of hypotension arise. There is a risk of elevated potassium levels in the blood, so patients at risk of hyperkalemia should have regular blood tests, and particular caution should be taken when using potassium supplements or medications containing potassium. Patients with impaired kidney function should monitor kidney function and serum electrolyte levels periodically during treatment with this medication. This drug may interact with other medications, so if other drugs are being taken, it is vital to inform healthcare professionals, especially when used in combination with specific heart medications, diuretics, anti-inflammatory drugs, and grapefruit juice. Women who are pregnant or breastfeeding should not take this medication, and if pregnancy is confirmed, use should be stopped immediately, and other treatment options should be explored. This medication is not recommended for children under the age of 18 due to insufficient evidence of safety and efficacy. Elderly patients may require dosage adjustments, particularly those over the age of 75 should start with a lower dose and increase gradually. In cases of overdose, symptoms such as hypotension, dizziness, and arrhythmia may occur, requiring immediate medical assistance and, if necessary, emergency care. This medication should be kept out of reach of children and should not be transferred to another container to maintain product quality.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to light, so it should be stored in a tightly sealed container that blocks light. Additionally, it is important to maintain a room temperature of 1 to 30 degrees Celsius while storing the medication to ensure its effectiveness is preserved.
White or slightly off-white, double convex, oval-shaped tablet
10 tablets/Alu-Alu X 3, 30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg
Tablet · Prescription medication · Combination
Hanwha Pharmaceutical Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
ILDONG Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.